blob: 84696d69e1f5560243e25c4f3c1339baf030d0b1 (
plain)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
|
<h2> Recomendation for
<abbr title="Severe Acute Respiratory Syndrome Coronavirus 2">SARS-CoV-2</abbr>
</h2>
### Guides
| Nº order | Documentation | Language |
| :------: | ------------------------------------------------------------ | :------: |
| 001 | [Manual de prevención][doc0] | ES |
| 002 | [¿cómo aislar a un familiar con sospecha de covid-19?][doc1] | ES |
## History Coronavirus in China
- <a href="https://github.com/invishantom/nCovMemory.git"><abbr title="Link to history of Coronavirus in China">nCovMemory</abbr></a>
<h2><abbr title="Severe Acute Respiratory Syndrome Coronavirus 2">SARS-CoV-2</abbr> Global Cases Maps</h2>
| Number | Organization |
| :----: |----------------------------------------------------------------------------------------- |
| 1 | [Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)][1] |
| 2 | [PAHO - Novel Coronavirus - COVID-2019- geographic distribution in the Americas][2] |
| 3 | [COVID-19 Italia - Monitoraggio della situazione][3] |
| 4 | [COVID-19 Coronavirus Map by stevenliuyi][4] |
| 5 | [Mapa de Covid 19 en el Perú - Ministerio del Salud][5] |
### CLI Maps
```console
$ curl https://corona-stats.online/
```
### Map of vaccination on continent America
<https://flo.uri.sh/visualisation/5178859/embed?auto=1>
## Informational links
| Country | URL | Language |
| :------ | :----------------------------------: | :------: |
| Chile | [Nitter - Ministerio de Salud][i-cl] | ES |
| Ecuador | [Nitter - Ministerio de Salud][i-ec] | ES |
| Perú | [Nitter - Ministerio de Salud][i-pe] | ES |
| Name | Language |
| :--------------------------------------------: | :------: |
| [Genome SARS-CoV-2][genome] | EN |
<h2><abbr title="World Health Organization">WHO</abbr> reports</h2>
| Name | SRC link | Local link | Language |
| :----------------------------------------------: | :--------: | :--------: | :------: |
| WHO china joint mission on covid 19 final report | [URL][r0] | [URL][r1] | EN |
## Docs
| Name | SRC link | Local link | Language |
|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------:|:----------:|:----------:|:--------:|
| COVID-19: IFRC, UNICEF and WHO issue guidance to protect children and support safe school operations | [URL][d0] | [URL][l0] | EN |
| How Long Should Social Distancing Last? Predicting Time to Moderation, Control, and Containment of COVID-19 | [URL][d1] | [URL][l1] | EN |
| Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 | [URL][d2] | [URL][l2] | EN |
| Will Coronavirus Pandemic Diminish by Summer? | [URL][d3] | [URL][l3] | EN |
| Stability of SARS-CoV-2 in different environmental conditions | [URL][d4] | [URL][l4] | EN |
| The proximal origin of SARS-CoV-2 | [URL][d5] | [URL][l5] | EN |
| Letter: Thrombotic Neurovascular Disease in COVID-19 Patients | [URL][d6] | [URL][l6] | EN |
| Draft landscape of COVID-19 candidate vaccines | [URL][d7] | [URL][l7] | EN |
| Sentinel surveillance of SARS-CoV-2 in wastewater anticipates the occurrence of COVID-19 cases | [URL][d8] | [URL][l8] | EN |
| Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia | [URL][d9] | [URL][l9] | EN |
| A phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS-COV-2rna vaccine candidates against COVID-19 in healthy individuals | [URL][d10] | [URL][l10] | EN |
| SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19 | [URL][d11] | [URL][l11] | EN |
## Vaccine
- [mRNA1273](https://en.wikipedia.org/wiki/MRNA-1273)
- [Sputnik V](https://en.wikipedia.org/wiki/Sputnik_V_COVID-19_vaccine)
- [Pfizer](https://en.wikipedia.org/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine)
| Name | Local Link | Language |
| :---------------: | :----------: | :--------: |
| ModeRNA | [URL][vac1] | ES |
| Pfizer-BioNTech | [URL][vac2] | ES |
| Sputnik V | [URL][vac3] | ES |
### References
- [First Person Injected With Trial Coronavirus Vaccine In Seattle](https://archive.fo/GK0nv)
- [In Vitro Antiviral Activity and Projection](https://archive.vn/cbkvW)
- [moderna - mRNA-1273](https://www.modernatx.com/mrna-1273)
- [COVID-19 Vaccine Clinical Trial Begins Today](https://www.veteranstoday.com/2020/03/16/covid-19-vaccine-clinical-trial-begins-today/)
- [clinicaltrials](https://clinicaltrials.gov/ct2/show/NCT04283461)
## Videos
| Name | Language |
| :---------------------------------------------------: | :------: |
| [Vacuna contra el coronavirus en Fase 1][v0] | ES |
| [COVID-19 Vaccine- Human Trial][v1] | EN |
| [Te explico por qué estoy preocupado de COVID-19][v2] | ES |
## License
This work is under the <a
href="https://www.gnu.org/licenses/fdl-1.3.html" rel="license"><abbr
title="GNU Free Documentation License">GFDLv1.3+</abbr></a> License
[doc0]: docs/covid-19.es.md
[doc1]: docs/como-aislar-familiar-sospecha-covid-19.md
[1]: https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
[2]: https://who.maps.arcgis.com/apps/webappviewer/index.html?id=2203b04c3a5f486685a15482a0d97a87
[3]: https://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/dae18c330e8e4093bb090ab0aa2b4892
[4]: https://covid19.health/
[5]: https://covid19.minsa.gob.pe/sala_situacional.asp
[i-cl]: https://nitter.snopyta.org/ministeriosalud
[i-ec]: https://nitter.snopyta.org/Salud_Ec
[i-pe]: https://nitter.snopyta.org/Minsa_Peru
[v0]: https://open.tube/videos/watch/538cfad2-04c5-4dbf-9e20-093c8a0586f3
[v1]: https://open.tube/videos/watch/047aa554-0808-4440-9191-e5691429dcbc
[v2]: https://open.tube/videos/watch/30540595-7605-49b5-8b9f-4ec1b751e086
[r0]: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
[r1]: docs/who-china-joint-mission-on-covid-19-final-report.pdf
[d0]: https://www.unicef.org/media/65716/file/Key%20Messages%20and%20Actions%20for%20COVID-19%20Prevention%20and%20Control%20in%20Schools_March%202020.pdf
[d1]: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3562996
[l0]: docs/Key-Messages-and-Actions-for-COVID-19-Prevention-and-Control-in-Schools_March-2020.pdf
[l1]: docs/SSRN-id3562996.pdf
[d2]: https://www.nejm.org/doi/pdf/10.1056/NEJMc2004973?articleTools=true
[l2]: docs/nejmc2004973.pdf
[d3]: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3556998
[l3]: docs/SSRN-id3556998.pdf
[d4]: https://www.thelancet.com/cms/10.1016/S2666-5247(20)30003-3/attachment/34ed069e-7268-42ae-8627-df3aa869d81b/mmc1.pdf
[l4]: docs/mmc1.pdf
[d5]: https://www.nature.com/articles/s41591-020-0820-9.pdf
[l5]: docs/s41591-020-0820-9.pdf
[d6]: https://academic.oup.com/neurosurgery/advance-article-pdf/doi/10.1093/neuros/nyaa254/33337496/nyaa254.pdf
[l6]: docs/thrombotic_neurovascular_disease.pdf
[d7]: https://www.who.int/docs/default-source/coronaviruse/novel-coronavirus-landscape-covid-195513b88a53a54fbb914c90ed9064f395.pdf
[l7]: docs/candidate_vaccines_covid_19.pdf
[d8]: https://www.medrxiv.org/content/10.1101/2020.06.13.20129627v1.full.pdf
[l8]: docs/sentinel-surveillance-of-SARS-CoV-2.pdf
[d9]: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2821%2900234-8
[l9]: docs/PIIS0140673621002348.pdf
[d10]: https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-11/C4591001_Clinical_Protocol_Nov2020.pdf
[l10]: docs/C4591001_Clinical_Protocol_Nov2020.pdf
[d11]: docs/Key-Messages-and-Actions-for-COVID-19-Prevention-and-Control-in-Schools_March-2020.pdf
[l11]: https://www.biorxiv.org/content/10.1101/2021.10.24.465626v1.full.pdf
[vac1]: docs/ModeRNA.pdf
[vac2]: docs/Pfizer-BioNTech.pdf
[vac3]: docs/Sputnik_V.pdf
[genome]: https://github.com/Hikoyu/SARS-CoV-2
|
